PDS Biotechnology Corporation
PDSB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $47,338 | $61,050 | $48,220 | $59,418 |
| - Cash | $26,198,652 | $31,873 | $39,979 | $41,690 |
| + Debt | $77,659 | $18,537 | $18,961 | $21,828 |
| Enterprise Value | -$26,073,655 | $47,714 | $27,202 | $39,557 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$15 |
| % Margin | – | – | – | – |
| EBITDA | -$7,859 | -$7,284 | -$8,722 | -$6,842 |
| % Margin | – | – | – | – |
| Net Income | -$9,009 | -$9,434 | -$8,489 | -$7,952 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.21 | -0.21 | -0.22 |
| % Growth | 9.5% | 0% | 4.5% | – |
| Operating Cash Flow | -$5,916 | -$9,101 | -$9,032 | -$8,234 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$5,916 | -$9,101 | -$9,032 | -$8,234 |